COVID-19 pet boom has veterinarians backlogged, burned out
FORT LAUDERDALE, Fla. — During the gloomiest stretches of the pandemic, Dr. Diona Krahn’s veterinary clinic has been a puppy fest, overrun with new four-legged patients.
88-year-old artist finishes year of pandemic ‘daily doodles’
WESTMORELAND, N.H. — Much like the round clock faces, gears and planets that often populate his artwork, Robert Seaman has come full circle.
US advisers endorse Pfizer COVID shot for kids 12 and up
U.S. health advisers on Wednesday endorsed use of Pfizer’s COVID-19 vaccine in kids as young as 12 — just as planned new guidelines say it’s OK for people of any age to get a coronavirus shot at the same time as other needed vaccinations.
Taming the virus: US deaths hit lowest level in 10 months
COVID-19 deaths in the United States have tumbled to an average of about 600 per day — the lowest level in 10 months — with the number of lives lost dropping to single digits in well more than half the states and, on some days, hitting zero.
Poll: Most in US who remain unvaccinated need convincing
Fewer Americans are reluctant to get a COVID-19 vaccine than just a few months ago, but questions about side effects and how the shots were tested still hold some back, according to a new poll that highlights the challenges at a pivotal moment in the U.S. vaccination campaign.
US schools fight to keep students amid fear of dropout surge
KANSAS CITY, Kan. — U.S. educators are doing everything they can to track down high school students who stopped showing up to classes and help them get the credits needed to graduate, amid an anticipated surge in the country’s dropout rate during the coronavirus pandemic.
Younger adolescents get ready to receive COVID-19 vaccine
MISSION, Kan. — Parents, schools and vaccine clinics rushed to begin inoculating younger adolescents Tuesday after U.S. regulators endorsed Pfizer’s COVID-19 vaccine for children as young as 12.
AP-NORC poll: Biden approval buoyed by his pandemic response
WASHINGTON — President Joe Biden is plunging into the next phase of his administration with the steady approval of a majority of Americans, according to a new poll from the Associated Press-NORC Center for Public Affairs Research. The survey shows Biden is buoyed in particular by the public’s broad backing for his handling of the coronavirus pandemic.
Pfizer COVID-19 shot expanded to US children as young as 12
U.S. regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12.
States push jobless from virus recession to return to work
STOWE, Vt. — Fourteen months after COVID-19 put hundreds of thousands of people out of work, the U.S. economy is rebounding and employers are desperate for workers.
US tribe shares vaccine with relatives, neighbors in Canada
BABB, Mont. — On a cloudy spring day, hundreds lined up in their cars on the Canadian side of the border crossing that separates Alberta and Montana. They had driven for hours and camped out in their vehicles in hopes of receiving the season’s hottest commodity — a COVID-19 vaccine — from a Native American tribe that was giving out its excess doses.
Unemployment claims fall to a pandemic low of 498K
WASHINGTON — The number of Americans seeking unemployment aid fell last week to 498,000, the lowest point since the coronavirus pandemic struck 14 months ago and a sign of the job market’s growing strength as businesses reopen and consumers step up spending.
Remote learning still widespread even after Biden hits goal
President Joe Biden met his goal of having most elementary and middle schools open for full, in-person learning in his first 100 days in office, according to new survey data, but the share of students choosing to return continues to lag far behind.
Study: Residents left big metros during pandemic for family
Cece Linder was living in a 770-square-foot apartment outside Washington, D.C., last spring when the area went into lockdown because of the coronavirus pandemic.
More support easing vaccine patent rules, but hurdles remain
GENEVA — Several world leaders Thursday praised the U.S. call to remove patent protections on COVID-19 vaccines to help poor countries obtain shots. But the proposal faces a multitude of hurdles, including resistance from the pharmaceutical industry.
Personal ties: Harris’ family in India grapples with COVID
WASHINGTON — G. Balachandran turned 80 this spring — a milestone of a birthday in India, where he lives. If not for the coronavirus pandemic, he would have been surrounded by family members who gathered to celebrate with him.
US backs waiving intellectual property rules on vaccines
WASHINGTON — The Biden administration on Wednesday joined calls for more sharing of the technology behind COVID-19 vaccines to help speed the end of the pandemic, a shift that puts the U.S. alongside many in the developing world who want rich countries to do more to get doses to the needy.
COVID’s US toll projected to drop sharply by the end of July
NEW YORK — Teams of experts are projecting COVID-19’s toll on the U.S. will fall sharply by the end of July, according to research released by the government Wednesday.
FDA expected to OK Pfizer vaccine for teens within week
WASHINGTON — The U.S. Food and Drug Administration is expected to authorize Pfizer’s COVID-19 vaccine for youngsters ages 12-15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.
Biden aims to vaccinate 70% of American adults by July 4
WASHINGTON — President Joe Biden on Tuesday set a new vaccination goal to deliver at least one shot to 70% of adult Americans by July Fourth as he tackles the vexing problem of winning over the “doubters” and those unmotivated to get inoculated.
